Gavi videos

Vaccines are still extremely effective at preventing severe disease. Waning antibody levels doesn’t always translate to lessening immunity.

Despite the havoc wrought by the COVID-19 pandemic on health systems worldwide, governments’ work to bring immunisation programmes back on track is paying off.

On Thursday 23 September, on the sidelines of the UN General Assembly, global health leaders gathered to discuss gender equality in healthcare worldwide. Here’s what happened.

A study looking at health issues such as stroke or seizures after COVID-19 vaccination showed that vaccines weren’t linked to any significant number of side effects.

Data from the UK suggests double vaccination lowers the risk of ongoing COVID-19 symptoms, as well as reducing hospitalisations and the severity of the initial illness.

More often than not, the road to a meaningful triumph is a bumpy one.

While most people jumped at the chance to get their COVID-19 vaccine, some have been more hesitant over concerns about safety.  Here we explain all the checks and balances in place to make sure the vaccines are safe.

More than a quarter of a million infants in low- and middle-income countries are predicted to have died in 2020 due to the economic impact of COVID-19.

COVID-19 has caused a decline in the delivery of human papillomavirus (HPV) vaccines that protect girls from cervical cancer. Anuradha Gupta, the Deputy CEO of Gavi, explains what we must do to create more access to these vaccines.

The way we live can shape the evolution of pathogens, for better or worse.

The latest IPCC report emphasises the inevitability of some degree of climate change. The human health impact of this should not be ignored.

Real-world data is starting shed light on the performance of COVID-19 vaccines in less than perfect conditions.